ACADIA Pharmaceuticals Inc. (ACAD)

NASDAQ: ACAD · Real-Time Price · USD

29.50

+0.46 (1.58%)

At close: Aug 21, 2026, 4:00 PM EDT

30.10

+0.60 (2.03%)

Pre-market: Aug 24, 2026, 7:15 AM EDT

ACADIA Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,139	1,072	957.8	726.44	517.24	484.15
Revenue Growth	11.75%	11.87%	31.85%	40.45%	6.83%	9.60%
Cost of Revenue	431.99	417.8	385.09	393.26	371.74	258.56
Gross Profit	706.66	653.71	572.71	333.18	145.49	225.59
Selling, General & Admin	620.29	548.89	488.43	406.56	369.09	396.03
Operating Expenses	620.29	548.89	488.43	406.56	369.09	396.03
Operating Income	86.37	104.81	84.28	-73.38	-223.6	-170.44
Interest & Investment Income	32.62	31.72	25.46	17.23	6.61	0.59
Other Non Operating Income (Expenses)	2.38	2.37	1.82	-	-	-
EBT Excluding Unusual Items	121.37	138.9	111.56	-56.15	-216.99	-169.85
Gain (Loss) on Sale of Investments	-	-	-	5.11	3.54	2.33
Gain (Loss) on Sale of Assets	-	-	146.52	-	-	-
Pretax Income	121.37	138.9	258.08	-51.04	-213.44	-167.52
Income Tax Expense	-259.12	-252.1	31.62	10.25	2.53	0.35
Net Income	380.48	391	226.45	-61.29	-215.98	-167.87
Net Income to Common	380.48	391	226.45	-61.29	-215.98	-167.87
Net Income Growth	71.27%	72.66%	-	-	-	-
Shares Outstanding (Basic)	170	168	166	164	162	160
Shares Outstanding (Diluted)	172	170	166	164	162	160
Shares Change	2.98%	2.14%	1.55%	1.32%	0.74%	2.01%
EPS (Basic)	2.24	2.32	1.37	-0.37	-1.34	-1.05
EPS (Diluted)	2.21	2.30	1.36	-0.37	-1.34	-1.05
EPS Growth	66.40%	69.12%	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	145.63	105.15	157.2	16.65	-114.04	-126.78
Free Cash Flow Per Share	0.84	0.62	0.94	0.10	-0.70	-0.79
Gross Margin	62.06%	61.01%	59.79%	45.87%	28.13%	46.59%
Operating Margin	7.58%	9.78%	8.80%	-10.10%	-43.23%	-35.20%
Profit Margin	33.42%	36.49%	23.64%	-8.44%	-41.76%	-34.67%
Free Cash Flow Margin	12.79%	9.81%	16.41%	2.29%	-22.05%	-26.19%
EBITDA	98.39	116.57	100.16	-67.83	-221.57	-167.1
EBITDA Margin	8.64%	10.88%	10.46%	-9.34%	-42.84%	-34.51%
D&A For EBITDA	12.02	11.76	15.88	5.55	2.03	3.34
EBIT	86.37	104.81	84.28	-73.38	-223.6	-170.44
EBIT Margin	7.58%	9.78%	8.80%	-10.10%	-43.23%	-35.20%
Effective Tax Rate	-	-	12.25%	-	-	-
Revenue as Reported	1,139	1,072	957.8	726.44	517.24	484.15
Advertising Expenses	-	31.9	21.1	9.4	5.5	41.8

SEC Filings: 10-K · 10-Q